246 related articles for article (PubMed ID: 28741789)
21. Design, synthesis of novel isoindoline hybrids as COX-2 inhibitors: Anti-inflammatory, analgesic activities and docking study.
Labib MB; Sharkawi SMZ; El-Daly M
Bioorg Chem; 2018 Oct; 80():70-80. PubMed ID: 30005203
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, biological evaluation, and enzyme docking simulations of 1,5-diarylpyrrole-3-alkoxyethyl ethers as selective cyclooxygenase-2 inhibitors endowed with anti-inflammatory and antinociceptive activity.
Anzini M; Rovini M; Cappelli A; Vomero S; Manetti F; Botta M; Sautebin L; Rossi A; Pergola C; Ghelardini C; Norcini M; Giordani A; Makovec F; Anzellotti P; Patrignani P; Biava M
J Med Chem; 2008 Aug; 51(15):4476-81. PubMed ID: 18598017
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, biological evaluation and molecular modeling of dihydro-pyrazolyl-thiazolinone derivatives as potential COX-2 inhibitors.
Qiu KM; Yan R; Xing M; Wang HH; Cui HE; Gong HB; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(22):6648-54. PubMed ID: 23062711
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
Kaur A; Pathak DP; Sharma V; Wakode S
Bioorg Med Chem; 2018 Feb; 26(4):891-902. PubMed ID: 29373271
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of key enzymes in the inflammatory pathway by hybrid molecules of terpenes and synthetic drugs: In vitro and in silico studies.
Theoduloz C; Alzate-Morales J; Jiménez-Aspee F; Isla MI; Alberto MR; Pertino MW; Schmeda-Hirschmann G
Chem Biol Drug Des; 2019 Mar; 93(3):290-299. PubMed ID: 30294891
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies.
Abdelgawad MA; Labib MB; Ali WAM; Kamel G; Azouz AA; El-Nahass ES
Bioorg Chem; 2018 Aug; 78():103-114. PubMed ID: 29550530
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1,2,4-triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti-inflammatory and analgesic agents.
Banerjee AG; Das N; Shengule SA; Srivastava RS; Shrivastava SK
Eur J Med Chem; 2015 Aug; 101():81-95. PubMed ID: 26117820
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3-c]pyrazol-4(1H)-ones as potential cyclooxygenase-2 (COX-2) inhibitors.
Grover J; Kumar V; Sobhia ME; Jachak SM
Bioorg Med Chem Lett; 2014 Oct; 24(19):4638-4642. PubMed ID: 25219899
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Cyclooxygenase Enzyme by Bioflavonoids in Horsegram Seeds Alleviates Pain and Inflammation.
Ramalingam M; Sali VK; Bhardwaj M; Mani S; Vasanthi HR
Comb Chem High Throughput Screen; 2020; 23(9):931-938. PubMed ID: 31985369
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, anti-inflammatory activity and molecular docking studies of 2,5-diarylfuran amino acid derivatives.
Stefani HA; Botteselle GV; Zukerman-Schpector J; Caracelli I; da Silva Corrêa D; Farsky SH; Machado ID; Santin JR; Hebeda CB
Eur J Med Chem; 2012 Jan; 47(1):52-8. PubMed ID: 22071254
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of novel 3,5,6-trisubstituted 2-pyridone derivatives and evaluation for their anti-inflammatory activity.
Gonçalves DS; de S Melo SM; Jacomini AP; J V da Silva M; Pianoski KE; Ames FQ; Aguiar RP; Oliveira AF; Volpato H; Bidóia DL; Nakamura CV; Bersani-Amado CA; Back DF; Moura S; Paula FR; Rosa FA
Bioorg Med Chem; 2020 Jun; 28(12):115549. PubMed ID: 32503692
[TBL] [Abstract][Full Text] [Related]
32. Anti-nociceptive and Anti-inflammatory Activities of Asparacosin A Involve Selective Cyclooxygenase 2 and Inflammatory Cytokines Inhibition: An
Karim N; Khan I; Khan W; Khan I; Khan A; Halim SA; Khan H; Hussain J; Al-Harrasi A
Front Immunol; 2019; 10():581. PubMed ID: 30972073
[TBL] [Abstract][Full Text] [Related]
33. Novel diphenylthiazole derivatives with multi-target mechanism: Synthesis, docking study, anticancer and anti-inflammatory activities.
Abdelazeem AH; El-Saadi MT; Said EG; Youssif BGM; Omar HA; El-Moghazy SM
Bioorg Chem; 2017 Dec; 75():127-138. PubMed ID: 28938224
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, biological evaluation and molecular modeling of novel selective COX-2 inhibitors: sulfide, sulfoxide, and sulfone derivatives of 1,5-diarylpyrrol-3-substituted scaffold.
Reale A; Brogi S; Chelini A; Paolino M; Di Capua A; Giuliani G; Cappelli A; Giorgi G; Chemi G; Grillo A; Valoti M; Sautebin L; Rossi A; Pace S; La Motta C; Di Cesare Mannelli L; Lucarini E; Ghelardini C; Anzini M
Bioorg Med Chem; 2019 Oct; 27(19):115045. PubMed ID: 31427145
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on bumetanide scaffold.
Ibrahim TS; Salem IM; Mostafa SM; El-Sabbagh OI; ElKhamisi MKM; Hegazy L; Elgendy B
Bioorg Chem; 2020 Jul; 100():103878. PubMed ID: 32361486
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities.
Abd El Razik HA; Mroueh M; Faour WH; Shebaby WN; Daher CF; Ashour HMA; Ragab HM
Chem Biol Drug Des; 2017 Jul; 90(1):83-96. PubMed ID: 28032452
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of novel pyrazole–thiadiazole hybrid as potential potent and selective cyclooxygenase-2 (COX-2) inhibitors.
Alegaon SG; Hirpara MB; Alagawadi KR; Hullatti KK; Kashniyal K
Bioorg Med Chem Lett; 2014 Nov; 24(22):5324-9. PubMed ID: 25444084
[TBL] [Abstract][Full Text] [Related]
38. Novel 1,5-diaryl pyrazole-3-carboxamides as selective COX-2/sEH inhibitors with analgesic, anti-inflammatory, and lower cardiotoxicity effects.
Hendawy OM; Gomaa HAM; Alzarea SI; Alshammari MS; Mohamed FAM; Mostafa YA; Abdelazeem AH; Abdelrahman MH; Trembleau L; Youssif BGM
Bioorg Chem; 2021 Nov; 116():105302. PubMed ID: 34464816
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors.
Abdellatif KRA; Abdelall EKA; Fadaly WAA; Kamel GM
Bioorg Med Chem Lett; 2016 Jan; 26(2):406-412. PubMed ID: 26691756
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, molecular docking, and pharmacological evaluation of N-(2-(3,5-dimethoxyphenyl)benzoxazole-5-yl)benzamide derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
Kaur A; Pathak DP; Sharma V; Wakode S
Arch Pharm (Weinheim); 2018 Jun; 351(6):e1800008. PubMed ID: 29741797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
